EUVIMED · CrossrefZeitschrift
Bone Marrow Transplantation
ISSN 0268-3369 · Springer Science and Business Media LLC
Neueste Artikel
Cryopreservation of academic CAR T-cell products: methodological recommendations from the EBMT practice harmonisation and guidelines committee
Metabolic tumor volume trajectory during bridging and association with outcomes after CAR T infusion in large B-cell lymphoma
Influence of CAR T-cell expansion and persistence in the peripheral blood on CAR T-cell therapy efficacy and adverse events in multiple myeloma
Proton pump inhibitors and outcome after axicabtagene ciloleucel for the treatment of non-Hodgkin B-cell lymphoma, a retrospective study with the DESCAR-T registry
Correction: T-cell replete haploidentical transplantation compared to mismatched unrelated allogeneic transplantation with post-transplantation cyclophosphamide in patients with secondary acute myeloid leukemia in first complete remission: a study from the ALWP/EBMT
The first attempts to transplant bone marrow—tribute to Jan Raszek-Rosenbusch and Franciszek Groër.
Metabolic pathways as therapeutic target to improve allo-HSCT outcomes
A real-world, multi-center, retrospective study of autologous hematopoietic stem cell transplantation in 33 patients with HIV-associated lymphoma in China (CALL-006 Study)
Real-world approaches to preventing acute myeloid leukemia relapse after allogeneic transplantation: a national survey by GITMO (Gruppo Italiano Trapianto Midollo Osseo)
Response kinetics following CAR T-cell therapy for large B-cell lymphoma: a LYSA study from the DESCAR-T registry
Improvement of signs of vulvovaginal chronic graft-versus-host disease and genital syndrome of menopause with non-ablative radiofrequency therapy
Incidence and risk factors of Epstein-Barr virus infection and post-transplant lymphoproliferative disorder in paediatric haploidentical allogeneic hematopoietic stem cell transplantation
Elevated plasma anandamide levels in sclerotic chronic graft-versus-host disease highlight the endocannabinoid system as a potential therapeutic target
Low muscle quality, but not muscle mass, in abdominal CT-scans associates with adverse outcomes in AML patients undergoing an allogeneic stem cell transplantation
Allogeneic hematopoietic cell transplantation for myelodysplastic syndromes harboring a paroxysmal nocturnal hemoglobinuria clone—a study on behalf of the Chronic Malignancies and Severe Aplastic Anemia Working Parties of the EBMT
Defining global priorities in hematopoietic transplantation and cellular therapy: a statement paper from EBMT Global Committee
Expanding the donor pool in secondary AML: a step forward, with caveats
Fecal microbiota transplantation in the treatment of acute graft-versus-host disease: A retrospective study performed by the Complications Working Party and Pediatric Diseases Working Party of the EBMT
Total body irradiation across conditioning intensities: historical context, dose–fractionation strategy, and the role of the chemotherapy backbone
Real-world CAR-T practice patterns in patients with mantle cell lymphoma: an international survey on behalf of the EBMT lymphoma working party
Long-term complications after total body irradiation in children younger than 4 years transplanted for acute lymphoblastic leukemia
Prognostic factors of second allogeneic hematopoietic stem cell transplantation for relapsed or refractory myelodysplastic syndromes: nationwide registry analysis
Treosulfan or busulfan plus clofarabine as reduced intensity conditioning regimen before allotransplant for adults with myeloid malignancies
Pregnancy outcomes in women conceiving after hematopoietic stem cell transplantation versus conventional chemotherapy for childhood or adolescent acute leukemia
Social vulnerability is not associated with reduced access to hematopoietic cell transplantation among referred pediatric patients with hematologic malignancies
Correction: Transplantation outcomes in Philadelphia-positive acute lymphoblastic leukemia with additional cytogenetic abnormalities: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
A randomized pilot trial comparing anti-thymocyte globulin with anti-thymocyte globulin plus post transplant cyclophosphamide for prophylaxis against acute and chronic graft versus host disease in matched donor hematopoietic cell transplants – a study from the Cell Therapy Transplant Canada/ Australasian Leukemia Lymphoma Group Consortium
Mycophenolate mofetil-based graft-versus-host disease prophylaxis is associated with an increased risk of human herpesvirus 6B encephalitis after cord blood transplantation
Use of an unrelated cord blood unit as an emergency rescue graft after last-minute donor collection cancellation
Publisher Correction: defining global priorities in hematopoietic transplantation and cellular therapy: a statement paper from the EBMT global committee
Jahrgänge
2026 · 2362025 · 3122024 · 3102023 · 2722022 · 3672021 · 4792020 · 3952019 · 3502018 · 2622017 · 3602016 · 3662015 · 3292014 · 3232013 · 3222012 · 3122011 · 3062010 · 3242009 · 2832008 · 4132007 · 3332006 · 3472005 · 4582004 · 4182003 · 4792002 · 4382001 · 5502000 · 6311999 · 5621998 · 4671997 · 432
EUVIMED